German healthcare reforms spark backlash over fairness and prevention gaps
German healthcare reforms spark backlash over fairness and prevention gaps
German healthcare reforms spark backlash over fairness and prevention gaps
Politicians from the Green and Left parties have spoken out against the government's latest healthcare reforms. Ricarda Lang and Gregor Gysi argue the plans lack social fairness and fail to prioritise preventive care. Their criticism comes as the government pushes ahead with cost-cutting measures worth billions. On 30 March 2026, the Finanzkommission Gesundheit unveiled a reform package aimed at saving up to 42 billion euros. The proposals include higher patient contributions, cuts to homeopathy funding, and stricter rules for skin cancer screenings. Evidence-based reimbursements will also be tightened, focusing on reducing the budget deficit rather than expanding services.
Lang, a Green Party leader, has rejected plans to end contribution-free co-insurance for dependents. She warned that the reforms disproportionately affect middle-income earners. While open to backing the chancellor's proposals, she insists any changes must ensure fairness. Gysi, leader of the Left Party, called for broader reforms linking health, labour, and family policies. He proposed a commission to examine these areas and urged insurers to fund early screenings to lower long-term treatment costs. He also criticised the government for ignoring tax disparities between wealthy German and Swiss families, arguing that higher taxes on the rich could ease pressure on the healthcare system. Both politicians stressed the need for stronger preventive care and financial relief for families. However, the government's draft law, expected by June 2026, shows no sign of adopting these demands, prioritising austerity over expanded services.
The current reform plans focus on cost savings and deficit reduction. Lang and Gysi's calls for social equity and prevention remain unaddressed in the government's proposals. A final draft of the law is due in mid-2026, with no indication of policy shifts towards their recommendations.